Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE3
100 participants
INTERVENTIONAL
2012-06-30
2012-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The study will be a prospective randomised trial.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mode of Induction in Fetal Growth Restriction and Its Affects on Fetal and Maternal Outcomes
NCT03625518
Induction of Labor - Comparison Propess With Prostaglandin E2 Vaginal Gel and Balloon Catheter
NCT06803992
Labor Induction With Dinoprostone in Oppose to Cervical Ripening Balloon as a Factor of BMI.
NCT03033264
Stepwise Labor Induction Following Failure of Prostaglandin Vaginal Insert for Labor Induction
NCT02684305
Induction of Labor in Patients With Unfavorable Cervical Conditions
NCT00604487
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
double balloon catheter
Cervical ripening by double balloon catheter
double balloon catheter
cervical ripening using double balloon catheter
prostaglandins E2
cervical ripening using prostaglandins E2
prostaglandins E2
prostaglandins E2 - Intravaginal Propess for 24 hours
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
double balloon catheter
cervical ripening using double balloon catheter
prostaglandins E2
prostaglandins E2 - Intravaginal Propess for 24 hours
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* normal pregnancy, well dated, at term
* un ripened cervix
Exclusion Criteria
* multiple pregnancy
* intra uterine growth restricted fetus
18 Years
55 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Meir Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tal Biron - Shental, MD
Role: PRINCIPAL_INVESTIGATOR
Meir Medical Center, Kfar Saba, Israel, Affiliated to Tel Aviv University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Meir Medial Center
Kfar Saba, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
034-2011-MMC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.